Insider Shareholders with Direct Ownership of Paratek Pharmaceuticals, Inc. (PRTK)
This section provides a comprehensive overview of the insiders with direct ownership of Paratek Pharmaceuticals, Inc. (PRTK). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Paratek Pharmaceuticals, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Michael Bigham
Exec. Chairman of the Board |
1,117,346 | 1,659,588 | 0 $0 | 25 |
Sep 21, 2023
Reduced 100.0%
|
|
Randall B. Brenner
Chief Development & Regulatory |
398,863 | 569,676 | 0 $0 | 24 |
Sep 21, 2023
Reduced 100.0%
|
|
William M. Haskel
CLO, General Counsel & Sec. |
420,863 | 619,553 | 0 $0 | 24 |
Sep 21, 2023
Reduced 100.0%
|
|
Evan Loh
CEO |
1,225,092 | 1,777,100 | 0 $0 | 25 |
Sep 21, 2023
Reduced 100.0%
|
|
Adam Woodrow
President & Chief Commercial |
604,796 | 875,469 | 0 $0 | 22 |
Sep 21, 2023
Reduced 100.0%
|
|
Minnie Baylor Henry
Director |
59,200 | 59,200 | 0 $0 | 4 |
Sep 21, 2023
Reduced 100.0%
|
|
Thomas John Dietz
Director |
49,000 | 69,250 | 0 $0 | 4 |
Sep 21, 2023
Reduced 100.0%
|
|
Kristine Peterson
Director |
49,000 | 79,000 | 0 $0 | 4 |
Sep 21, 2023
Reduced 100.0%
|
|
Jeffrey Stein
Director |
49,000 | 75,625 | 0 $0 | 5 |
Sep 21, 2023
Reduced 100.0%
|
|
Robert S Radie
Director |
49,000 | 73,000 | 0 $0 | 4 |
Sep 21, 2023
Reduced 100.0%
|
|
Rolf K Hoffmann
Director |
49,000 | 84,000 | 0 $0 | 4 |
Sep 21, 2023
Reduced 100.0%
|
|
Timothy R Franson
Director |
49,000 | 79,000 | 0 $0 | 5 |
Sep 21, 2023
Reduced 100.0%
|